Drug intelligence / Profile preview

PCV-Cas9

Development stage
Preclinical
Lead developer
Institute of Bioorganic Chemistry
Modality
CRISPR-Cas9 → CRISPR Systems → Programmable Nucleases → Gene Editing → Gene Therapies
Administration
Ex Vivo
01

Overview

PCV-Cas9 is an engineered CRISPR/Cas9 system designed to enhance the precision of genome editing by promoting Homology Directed Repair (HDR). It consists of a Porcine Circovirus 2 (PCV) Rep protein DNA-binding domain fused to either wild-type Cas9 (PCV-wtCas9) or a nickase variant (PCV-nCas9). This fusion protein allows for the covalent tethering of a single-stranded oligodeoxynucleotide (ssODN) donor template directly to the Cas9-guide RNA ribonucleoprotein (RNP) complex. By spatially and temporally co-localizing the double-strand break (DSB) machinery with the repair template, the system shifts the DNA repair balance away from Non-Homologous End Joining (NHEJ) toward precise HDR. It is being investigated by researchers at the Institute of Bioorganic Chemistry, Polish Academy of Sciences, primarily for the correction of the point mutation in the β-globin gene associated with Sickle Cell Disease (SCD).

Other names
Porcine Circovirus 2 Rep protein-Cas9 fusion
02

Targets

Hb (Hemoglobin)

Beyond the preview

Go deeper on PCV-Cas9.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PCV-Cas9.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call